Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer

Background In clinically node-negative breast cancer patients, the INSEMA trial (NCT02466737) assessed the noninferiority of avoiding sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Here we present patient-reported outcomes (PROs) as a secondary endpoint.

Bibliographic Details

Main Authors:	Reimer, Toralf (Author) , Stachs, Angrit (Author) , Veselinovic, Kristina (Author) , Polata, Silke (Author) , Müller, Thomas (Author) , Kühn, Thorsten (Author) , Heil, Jörg (Author) , Ataseven, Beyhan (Author) , Reitsamer, Roland (Author) , Hildebrandt, Guido (Author) , Knauer, Michael (Author) , Golatta, Michael (Author) , Stefek, Andrea (Author) , Zahm, Dirk-Michael (Author) , Thill, Marc (Author) , Nekljudova, Valentina (Author) , Krug, David (Author) , Loibl, Sibylle (Author) , Gerber, Bernd (Author)
Format:	Article (Journal)
Language:	English
Published:	January 2023
In:	EClinicalMedicine Year: 2023, Volume: 55, Pages: 1-12
ISSN:	2589-5370
DOI:	10.1016/j.eclinm.2022.101756
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.eclinm.2022.101756 Verlag, lizenzpflichtig, Volltext: https://linkinghub.elsevier.com/retrieve/pii/S2589537022004850
Author Notes:	Toralf Reimer, Angrit Stachs, Kristina Veselinovic, Silke Polata, Thomas Müller, Thorsten Kühn, Jörg Heil, Beyhan Ataseven, Roland Reitsamer, Guido Hildebrandt, Michael Knauer, Michael Golatta, Andrea Stefek, Dirk-Michael Zahm, Marc Thill, Valentina Nekljudova, David Krug, Sibylle Loibl, and Bernd Gerber, a on behalf of the INSEMA investigators